The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 12, 2011
Filed:
Apr. 18, 2008
Peter Hornbeck, Magnolia, MA (US);
Ailan Guo, Burlington, MA (US);
Ting-lei Gu, Woburn, MA (US);
Klarisa Rikova, Reading, MA (US);
Albrecht Moritz, Salem, MA (US);
Charles Farnsworth, Concord, MA (US);
Matthew Stokes, Beverly, MA (US);
Jian Yu, Hamilton, MA (US);
Erik Spek, Cambridge, MA (US);
Yu LI, Andover, MA (US);
Anthony Possemato, Framingham, MA (US);
Jessica Cherry, Durham, NH (US);
Valerie Goss, Seabrook, NH (US);
Jeffrey Mitchell, Nashua, NH (US);
John Rush, Beverly, MA (US);
Corinne Michaud, Salem, MA (US);
Peter Hornbeck, Magnolia, MA (US);
Ailan Guo, Burlington, MA (US);
Ting-Lei Gu, Woburn, MA (US);
Klarisa Rikova, Reading, MA (US);
Albrecht Moritz, Salem, MA (US);
Charles Farnsworth, Concord, MA (US);
Matthew Stokes, Beverly, MA (US);
Jian Yu, Hamilton, MA (US);
Erik Spek, Cambridge, MA (US);
Yu Li, Andover, MA (US);
Anthony Possemato, Framingham, MA (US);
Jessica Cherry, Durham, NH (US);
Valerie Goss, Seabrook, NH (US);
Jeffrey Mitchell, Nashua, NH (US);
John Rush, Beverly, MA (US);
Corinne Michaud, Salem, MA (US);
Cell Signaling Technology, Inc., Danvers, MA (US);
Abstract
The invention discloses 482 novel phosphorylation sites identified in carcinoma and/or leukemia, peptides (including AQUA peptides) comprising a phosphorylation site of the invention, antibodies specifically bind to a novel phosphorylation site of the invention, and diagnostic and therapeutic uses of the above.